Literature DB >> 30654811

Correction to: Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies.

Elif Nurtop1, Paola Mariela Saba Villarroel2,3, Boris Pastorino2, Laetitia Ninove2, Jan Felix Drexler4, Yelin Roca3, Bouba Gake2,5, Audrey Dubot-Peres2, Gilda Grard2,6, Christophe Peyrefitte2,6, Stéphane Priet2, Xavier de Lamballerie2, Pierre Gallian2,7.   

Abstract

In the original publication of this article [1], Table 1 has some errors.

Entities:  

Year:  2019        PMID: 30654811      PMCID: PMC6337804          DOI: 10.1186/s12985-019-1118-8

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


Correction to: Virol J https://doi.org/10.1186/s12985-018-1105-5 In the original publication of this article [1], Table 1 has some errors. The correct one is below:
Table 1

Comparison of VNT and PRNT assays for a panel of 142 samples

VNTPRNT50PRNT90
Positive (titre ≥10)Negative (titre < 10)Positive (titre ≥10)Negative (titre < 10)
Positive (titre ≥40)511511
Negative (titre < 40)981189
Sensitivity of VNT(95% CI)85% (51/60)(72.9–92.4%)98.8% (51/52)(88.4–99.9%)
Specificity of VNT(95% CI)98.7% (81/82)(92.4–99.9%)98.8% (89/90)(93.1–99.9%)
Comparison of VNT and PRNT assays for a panel of 142 samples The publisher apologizes to the readers and authors for the inconvenience. The original publication has been corrected.
  1 in total

1.  Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies.

Authors:  Elif Nurtop; Paola Mariela Saba Villarroel; Boris Pastorino; Laetitia Ninove; Jan Felix Drexler; Yelin Roca; Bouba Gake; Audrey Dubot-Peres; Gilda Grard; Christophe Peyrefitte; Stéphane Priet; Xavier de Lamballerie; Pierre Gallian
Journal:  Virol J       Date:  2018-12-27       Impact factor: 4.099

  1 in total
  3 in total

1.  Selection of plasma donors for the production of anti-SARS-CoV-2 immunoglobulin-based therapies: Strategies for quantitative antibody measurements.

Authors:  Bruno Deltreggia Benites; Carolina Costa-Lima; Fernanda Batista Rosa Pinto; Vitor Antonio da Costa; Adriana da Silva Santos Duarte; Audrey Basso Zangirolami; Emerson Clayton Amaro; Fabiana Granja; José Luiz Proenca-Modena; Sara Terezinha Olalla Saad; Marcelo Addas-Carvalho
Journal:  Transfus Apher Sci       Date:  2022-07-19       Impact factor: 2.596

Review 2.  Microfluidic Point-of-Care (POC) Devices in Early Diagnosis: A Review of Opportunities and Challenges.

Authors:  Shih-Mo Yang; Shuangsong Lv; Wenjun Zhang; Yubao Cui
Journal:  Sensors (Basel)       Date:  2022-02-18       Impact factor: 3.576

3.  Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.

Authors:  Gururaj Rao Deshpande; Gajanan N Sapkal; Bipin N Tilekar; Pragya D Yadav; Yogesh Gurav; Shivshankar Gaikwad; Himanshu Kaushal; Ketki S Deshpande; Ojas Kaduskar; Prasad Sarkale; Srikant Baradkar; Annasaheb Suryawanshi; Rajen Lakra; A P Sugunan; Anukumar Balakrishnan; Priya Abraham; Pavan Salve
Journal:  Indian J Med Res       Date:  2020 Jul & Aug       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.